SCHEMBL862463

SCHEMBL862463

O=C(NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1c(-c2ccc[nH]c2=O)c2cc(Cl)ccc2n1Cc1cc(F)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PPARG P37231 9/20 0.43
CYP2C8 P10632 1/20 0.39
FLT1 P17948 5/20 0.39
FLT4 P35916 5/20 0.39
KDR P35968 5/20 0.39
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
SCN5A Q14524 1/20 0.35
PTGDR2 Q9Y5Y4 2/20 0.35
CCR9 P51686 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL862560 0.94 FLT1 (0.42) PPARGCYP2C8FLT1FLT4KDR
SCHEMBL862166 0.94 CYP2C8 (0.42) PPARGCYP2C8FLT1FLT4KDR
SCHEMBL862187 0.93 PPARG (0.48) PPARGCYP2C8
SCHEMBL832498 0.92 CYP2C8 (0.45) PPARGCYP2C8FLT1FLT4KDR
SCHEMBL862136 0.91 SERPINE1 (0.43) PPARGCYP2C8FLT1FLT4KDR
SCHEMBL10256531 0.91 FLT1 (0.41) PPARGCYP2C8FLT1FLT4KDR
SCHEMBL832619 0.91 CYP2C8 (0.41) PPARGCYP2C8FLT1FLT4KDR
SCHEMBL862717 0.90 CYP2C8 (0.42) PPARGCYP2C8FLT1FLT4KDR
SCHEMBL862164 0.90 CYP2C8 (0.42) PPARGCYP2C8FLT1FLT4KDR
SCHEMBL862158 0.90 CYP2C8 (0.41) PPARGCYP2C8FLT1FLT4KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143305-B2 2,3-substituted indole derivatives for treating viral infections SCHERING CORPORATION (US) 2012-03-27 US disclosed
US-20110033417-A1 2,3-SUBSTITUTED INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS MERCK SHARP & DOHME CORP. 2011-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110033417-A1 2,3-SUBSTITUTED INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS IDO2, IDO1, IRF3 PPARG 4093/4885CYP2C8 847/4885FLT1 3635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.